AI4Eyes announces C$3.7m internal financing alongside C$2.8m non-dilutive funding
AI4Eyes secured C$6.5 million across an internal investor financing and non-dilutive funding to support regulatory and clinical development.
Financing and company context
The January announcement describes a C$3.7 million financing from existing investors completed in the fourth quarter of 2025, plus C$2.8 million in non-dilutive support. The C$6.5 million headline combines those components.
The capital supports Canadian and US regulatory activities, product development, data collection and clinical trials. AI4Eyes also plans commercialization partnerships and leadership hiring; the financing announcement does not establish completed regulatory approval.